Email a Friend
Printer Friendly
Slashdot It!
Submit to Reddit
Add to Facebook

New ways to disarm deadly South American hemorrhagic fever viruses

March 09, 2010

New World hemorrhagic fevers are emerging infectious diseases found in South America that can cause terrible, Ebola-like symptoms. Current treatments are expensive and only partially effective.

Now, Howard Hughes Medical Institute (HHMI) researchers have discovered exactly how one type of New World hemorrhagic fever virus latches onto and infects human cells, offering a much-needed lead toward new treatments.

"New World hemorrhagic fevers are nasty, serious, and often fatal diseases," says Stephen C. Harrison, an HHMI investigator at Harvard Medical School and senior author of the report, published March 7, 2010, in Nature Structural & Molecular Biology. "The need for new interventions is high."

Arenaviruses, the infectious agents that cause New World hemorrhagic fevers, circulate naturally in rodents and can infect people who are in close contact with the animals. Symptoms include severe inflammation and bleeding from the mouth, nose, eyes, and other orifices. Most outbreaks occur in rural regions of Bolivia, Venezuela, Argentina, and Brazil. "The outbreaks of New World hemorrhagic fever tend to be brief and brutal, with mortality rates of 20 to 30 percent," says Jonathan Abraham, an M.D./Ph.D. candidate at Harvard University and first author of the paper. "These viruses aren't a huge public health issue yet, but you could say the New World hemorrhagic fevers are an emerging disease threat."

Researchers have known about these viruses since the 1960s, but the molecular basis of the disease has only been tackled recently, says Abraham, whose graduate studies are funded by HHMI through a Gilliam Fellowship for Advanced Study. The Gilliam Fellowships program currently supports the doctoral education of 30 exceptional students from disadvantaged backgrounds.

In 2007, Abraham was working with Boston Children's Hospital virologist Hyeryun Choe when he was co-first author on a report in Nature identifying the human cell surface receptor that the Machupo virus, an arenavirus, grabs to gain access to the human cell it is infecting. The receptor, called transferrin receptor 1, offers a handhold for Machupo virus as it invades cells in the body. Nearly every human cell displays the transferrin receptor, which ferries iron into cells.

Abraham then brought the project to Harrison, who had mentored the young scientist in 2004 as part of HHMI's Exceptional Research Opportunities Program (EXROP), which places undergraduate students from disadvantaged backgrounds in the laboratories of HHMI investigators and HHMI professors. The pairing was fortuitous. In Choe's laboratory, Abraham had developed methods to produce the Machupo virus surface protein, which links to the human transferrin receptor. Meanwhile, Harrison had stocks of purified transferrin receptor because he had previously worked to image the molecule and understood its molecular structure.

Together, the pair made batches of the Machupo surface protein bound to the transferrin receptor and then set about creating an image showing how the two molecules connected. They used x-ray crystallography, a technique in which protein crystals are bombarded with x-ray beams. As the x-rays pass through and bounce off of atoms in the crystal, they produce a diffraction pattern, which can then be analyzed to determine the three-dimensional shape of the protein. After a data collection trip to the powerful x-ray beam at Argonne National Laboratory in Illinois, Abraham and Harrison were able to examine the atomic structure of the Machupo surface protein attached to the transferrin receptor.

The images show that the Machupo surface protein binds to the transferrin receptor in a surprising way-using a loop called the apical domain. The biological function of this loop in humans is unknown, Harrison says. Other segments of the receptor bind iron-bearing transferrin, but the apical domain appears to be uninvolved in that process. "We don't know the normal function of the apical domain. Obviously it didn't evolve just to give Machupo virus a way to infect humans, but that's what the virus has evolved to latch onto," he says.

Because the apical domain is not involved in the critical task of moving iron into cells, Harrison says it presents an attractive target for drugs. In theory, an antibody designed to attach to the apical domain would prevent the Machupo virus from attaching to cells, blocking infection. One possible treatment strategy, then, would be to infuse patients with such an antibody during the early stages of infection, which might slow the infection enough to let patients recover.

Harrison says the finding might also help virologists predict which of the 22 known arenaviruses might be capable of infecting humans. Only five are known to infect humans now-and all of those bind to the human transferrin receptor. Presumably the other 17 viruses produce surface proteins that are unable to bind to the human transferrin receptor, Harrison says.

For Abraham, the idea of finding a treatment for these New World hemorrhagic fevers is close to his heart. His family hails from Haiti, where there is a "huge burden of infectious diseases. I'd like to dedicate my career to studying pathogens in underserved parts of the world," he says.

Howard Hughes Medical Institute

Related Hemorrhagic Fevers Current Events and Hemorrhagic Fevers News Articles

Hemorrhagic Fevers Current Events and Hemorrhagic Fevers News RSS

Wallabies and Bats Harbor
Modern marsupials may be popular animals at the zoo and in children's books, but new findings by University at Buffalo biologists reveal that they harbor a "fossil" copy of a gene that codes for filoviruses, which cause Ebola and Marburg hemorrhagic fevers and are the most lethal viruses known to humans.

Peregrine reports new study from Duke shows anti-HIV potential of targeting PS on cells
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced the publication of data showing phosphatidylserine (PS)-targeting antibodies can block one of the key ways the AIDS virus gains entry into certain blood cells.

Global warming linked to European viral epidemic
An epidemic of the viral disease nephropathia epidemica (NE) has been linked to increases in the vole population caused by hotter summers, milder winters and increased seedcrop production by broadleaf trees.

Nature Medicine study shows Peregrine's bavituximab can cure lethal virus infections
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) today reported publication of data in Nature Medicine that supports the broad anti-viral potential of the company's novel anti-phosphatidylserine (anti-PS) antibody platform, showing that its PS-targeting drug bavituximab can cure lethal virus infections in animal disease models.

'GreeneChip' — New diagnostic tool that rapidly and accurately identifies multiple pathogens
Researchers in the Greene Infectious Disease Laboratory at Columbia University Mailman School of Public Health and their colleagues in the WHO Global Laboratory Network have developed a new tool for pathogen surveillance and discovery-the GreeneChip System.

Researchers discover key mechanism by which lethal viruses Ebola and Marburg cause disease
Researchers in the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health, the Centers for Disease Control and Prevention, and the Caribbean Primate Research Center have discovered a key mechanism by which the Filoviruses, Ebola and Marburg, cause disease.

Genome circularization and RNA virus replication
As featured on the cover of the August 15th issue of G&D, an Argentinian research team, led by Dr. Andrea Gamarnik, report on their recent discovery of a novel mechanism of dengue virus replication.

Mailman School of Public Health researchers develop diagnostic test for pathogens
Researchers at the Greene Infectious Disease Laboratory at Columbia University's Mailman School of Public Health led by Thomas Briese, PhD, associate professor of Epidemiology, have developed a rapid, comprehensive diagnostic test for viral hemorrhagic fevers caused by the Ebola and Marburg viruses, as well as others.

Experimental vaccine protects nonhuman primates from Lassa fever
A team of U.S. and Canadian scientists has developed a vaccine against Lassa fever that fully protects nonhuman primates from experimental infection with lethal doses of Lassa virus.

More Hemorrhagic Fevers Current Events and Hemorrhagic Fevers News Articles

	The Official Patient's Sourcebook on Ebola Hemorrhagic Fever: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This sourcebook has been created for patients who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells patients where and how to look for information covering virtually all topics related to ebola hemorrhagic fever, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on ebola hemorrhagic fever. Following an introductory chapter, the sourcebook is...
	Hemorrhagic Fever Thunderhole (Primary Contributor)
	Biological, Chemical, and Radiological Terrorism: Emergency Preparedness and Response for the Primary Care Physician by Springer This book helps primary care physicians understand their roles in preparing for and responding to terrorist events. With a practical approach, the text considers the physical and psychological impact of terrorism on providers and patients who are directly affected, as well as the spillover effects in more distant geographic locals. Proactive measures are outlined, such as educating patients about protective recommendations, addressing concerns about risk, and reporting credible risks to the proper authorities. The text also details how to detect terrorist-caused illness as early as possible, how to provide therapy to defend against or prevent illness, and how to treat patients with terrorist-caused illness. In-depth coverage of biologic agents (anthrax, plague, smallpox, botulism,...
	The Official Patient's Sourcebook on Viral Hemorrhagic Fevers: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This sourcebook has been created for patients who have decided to make education and Internet-based research an integral part of the treatment process. Although it gives information useful to doctors, caregivers and other health professionals, it also tells patients where and how to look for information covering virtually all topics related to viral hemorrhagic fevers, from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on viral hemorrhagic fevers. Following an introductory chapter, the sourcebook...
	Hemorrhagic Fever With Renal Syndrome, Tick-And Mosquito- Borne Viruses: Archives of Virology, Supplementum 1 (Archives of Virology Supplement) by C. H. Calisher (Editor)
	Bibliography of hemorrhagic fever with renal syndrome (muroid virus nephropathy) by D. Carleton Gajdusek (Author)
	The Official Patient's Sourcebook on Marburg Hemorrhagic Fever: A Revised and Updated Directory for the Internet Age by Icon Health Publications (Author) This book has been created for patients who have decided to make education and research an integral part of the treatment process. Although it also gives information useful to doctors, caregivers and other health professionals, it tells patients where and how to look for information covering virtually all topics related to marburg hemorrhagic fever (also green monkey virus disease), from the essentials to the most advanced areas of research. The title of this book includes the word official. This reflects the fact that the sourcebook draws from public, academic, government, and peer-reviewed research. Selected readings from various agencies are reproduced to give you some of the latest official information available to date on marburg hemorrhagic fever. Given patients' increasing...
	Crimean-Congo Hemorrhagic Fever: A Global Perspective by Onder Ergonul (Editor), Chris A. Whitehouse (Editor) Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease associated with severe hemorrhagic manifestations. CCHF has been referred to as the "Asian Ebola." However, in fact, the disease is one of the most widely distributed tick-borne diseases in the world, occurring in Africa, Asia, Europe, and the Middle East. This volume covers major aspects of this important disease and the virus which causes it. Chapters are written by leading experts in their fields and detail historical, public health, epidemiological, and clinical aspects of CCHF and the genetics and molecular biology of the virus. Additional chapters focus on disease control, tick vectors and infection among animals, both natural and experimental. This book will be of interest to virologists, microbiologists,...
	Dengue Fever and Other Hemorrhagic Viruses (Deadly Diseases and Epidemics) by Tritha, Ph.D. Chakraborty (Author) Dengue fever is an infectious disease found around the world that is caused by four closely related, but distinct, types of viruses commonly transmitted by Aedes aegypti mosquitoes. Triggering excessive bleeding, dengue fever, dengue hemorrhagic fever, and dengue hemorrhagic shock can be fatal. "Dengue Fever and Other Hemorrhagic Viruses" explores the biology of the dengue virus and similar viruses such as Ebola, Marburg virus, and Lassa fever, as well as their symptoms, where they are commonly found, how they are transmitted, and the efforts to treat and eradicate them.Chapters include: Ins and Outs of Dengue; Hemorrhagic Fevers; Vectors - Bugs That Carry Disease; The Immune System: Our Line of Defense; and, Vaccination - Waking Up the Army in Us.
	Viral load as predictor of crimean-congo hemorrhagic fever outcome.(Clinical report): An article from: Emerging Infectious Diseases by Darja Duh (Author), Ana Saksida (Author), Miroslav Petrovec (Author), Salih Ahmeti (Author), Iusuf Dedushaj (Author), Marcus Panning (Author), Christian Drosten (Author), Tatjana Avsic-Zupanc (Author) This digital document is an article from Emerging Infectious Diseases, published by Thomson Gale on November 1, 2007. The length of the article is 2344 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: Viral load as predictor of crimean-congo hemorrhagic fever outcome.(Clinical report) Author: Darja Duh Publication: Emerging Infectious Diseases (Magazine/Journal) Date: November 1, 2007 Publisher: Thomson Gale Volume: 13 Issue: 11 Page: 1769(4) Article Type: Clinical report Distributed by Thomson...